Therapies On The Horizon is a new course introducing the newest upcoming therapies being researched in multiple myeloma. Elranatamab is one of these upcoming therapies. It is a bi-specific T-cell engaging antibody and works by getting the patient's immune cells to attack cancer cells directly. It is an off-the-shelf treatment that can be given right when the patient needs it. Watch the video below for more information! You can watch the full course on HealthTree University.
We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
about the author
Cynthia Chmielewski
Cynthia (Cindy) Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University. You can follow her on Twitter @myelomateacher
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.